J Sieper Selected Research

TNFR-Fc fusion protein (etanercept)

12/2006	Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
02/2006	Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.
12/2005	Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.
09/2005	Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
08/2005	Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept.
03/2005	Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
12/2004	Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis.
06/2003	Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept.
06/2003	Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

41	Ankylosing Spondylitis 03/2008 - 06/2000
7	Necrosis 03/2008 - 04/2000
4	Rheumatoid Arthritis 07/2003 - 04/2000
3	Reactive Arthritis (Reiter Disease) 06/2002 - 02/2000
2	Osteoarthritis 06/2002 - 11/2000
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2007
1	Back Pain (Backache) 09/2006
1	Inflammation 12/2005
1	Anterior Uveitis 08/2005
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2002
1	Mixed Connective Tissue Disease (MCTD) 01/2002
1	Syndrome 01/2002

17	infliximab (Remicade)FDA Link 03/2008 - 06/2000
9	TNFR-Fc fusion protein (etanercept)FDA Link 12/2006 - 06/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 06/2000
3	Methotrexate (Mexate)FDA LinkGeneric 03/2007 - 04/2000
3	AntigensIBA 06/2002 - 12/2000
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2006 - 04/2002
2	Aggrecans (Aggrecan)IBA 05/2005 - 07/2003
1	celecoxib (Celebrex)FDA Link 03/2008
1	Diclofenac (SR 38)FDA LinkGeneric 03/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2006
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2005
1	leflunomide (Arava)FDA LinkGeneric 01/2005
1	pamidronate (APD)FDA LinkGeneric 08/2003
1	Interferon-gamma (Interferon, gamma)IBA 06/2003
1	HLA-DRB1 antigen (HLA DRB1)IBA 06/2002
1	Prednisolone (Predate)FDA LinkGeneric 01/2002
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2002
1	Carbon MonoxideIBA 01/2002
1	RadiumIBA 04/2001
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2001
1	Interleukin-1 (Interleukin 1)IBA 11/2000
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2000
1	AntibodiesIBA 11/2000
1	Interleukin-10 (Interleukin 10)IBA 04/2000
1	Interleukin-4 (Interleukin 4)IBA 04/2000
1	Chaperonin 60IBA 02/2000